Engineering multifunctional nanoparticles to selectively target multiple myeloma cells and overcome cell adhesion mediated drug resistance.
cleavage. Importantly, multifunctional nanoparticles were more efficacious than doxorubicin in the presence of fibronectin (IC50=0.15�0.04 M and 0.42�0.09 M, respectively), and overcame CAM-DR induced by adherence…

